<ѻý>Hemoglobin Targets a Good Idea for Massively Transfused Patientsѻý> Outcomes improved with values approaching 10 g/dL Oct 16, 2023
<ѻý>Suzanne Somers Dies; FDA Plans to Ban Hair Relaxers; Health Worker Minimum Wageѻý> Health news and commentary from around the Web gathered by ѻý staff Oct 16, 2023
<ѻý>Study Validates Accuracy of PREDICT Prognostication Tool in Breast Cancerѻý> Findings suggest it's a suitable decision aid for U.S. oncologists and patients Oct 13, 2023
<ѻý>Cryoprecipitate, REBOA Flop for Improving Major Hemorrhage Outcomesѻý> The first randomized trials of both approaches failed Oct 13, 2023
<ѻý>Hair Relaxers' Cancer Risk; Genetic Test Aids Rural Care; Drug Negotiation Fallout?ѻý> News, features, and commentary about cancer-related issues Oct 13, 2023
<ѻý>New Lung Cancer Cases Are Higher in Younger Women vs Menѻý> And the higher incidence rates now extend to women ages 50 to 54 as well Oct 12, 2023
<ѻý>Combination Therapy Wins FDA Approval for BRAF-Mutated NSCLCѻý> Encorafenib plus binimetinib led to 75% ORR in untreated patients, 59% in treated patients Oct 12, 2023
<ѻý>'Abortion Test' Sparks Concern; AI in Brain Surgery; 'Is There a Doctor on Board?'ѻý> Health news and commentary from around the Web gathered by ѻý staff Oct 12, 2023
<ѻý>Rare Lung Bleeds Cluster in DOAC Users, Implications Unclearѻý> Pattern found in diffuse alveolar hemorrhage reports in FAERS Oct 11, 2023
<ѻý>Primary Care Intervention Improved Follow-Up of Abnormal Cancer Screening Resultsѻý> Follow-up testing within 120 days was improved with EHR reminders, patient outreach, navigation Oct 10, 2023
<ѻý>HER3-Targeted Drug Active in Advanced/Metastatic Breast Cancerѻý> Durable responses across all three major subtypes of breast cancer Oct 10, 2023
<ѻý>How a Multi-Cancer Screening Test Would Play Out in the Clinicѻý> True positives identified with Grail's assay typically confirmed in under 2 months Oct 10, 2023
<ѻý>Chemo Shortage: 'Paycheck to Paycheck'; Cancer Blood Test Shines; Struggling to Liveѻý> News, features, and commentary about cancer-related issues Oct 06, 2023
<ѻý>Bladder-Sparing Neoadjuvant Protocol Gets High Marks for MIBCѻý> Complete clinical response predicted favorable outcomes for up to 2 years Oct 06, 2023
<ѻý>Sotorasib's Confirmatory Data in NSCLC Unreliable, Says FDA Panelѻý> But agency doesn't plan to immediately push for KRAS inhibitor's withdrawal Oct 05, 2023
<ѻý>Can ctDNA Guide Radiation Use in Oligometastatic NSCLC?ѻý> Detectable circulating tumor DNA before radiotherapy linked with worse survival Oct 05, 2023
<ѻý>FDA Panel Endorses DFMO for Kids' High-Risk Neuroblastoma in Remissionѻý> Large improvement in event-free survival, but questions linger about sources of data Oct 04, 2023
<ѻý>Use of Recent Diagnostic CT Scans for Palliative RT Planning Reduced Treatment Timeѻý> Time to treatment completion slashed by over 4 hours compared with CT simulation planning Oct 04, 2023
<ѻý>Drugmaker Plans to Pull Lung Cancer Therapy From the Marketѻý> Randomized trial of mobocertinib (Exkivity) failed to confirm benefit in rare tumor type Oct 04, 2023
<ѻý>FDA Staff Highly Skeptical of Confirmatory Data on KRAS Inhibitor in NSCLCѻý> Reviewers see potentially tiny PFS benefit with sotorasib, raise concerns over "systemic bias" Oct 04, 2023
<ѻý>Hypofractionated RT for Breast Cancer Post-Mastectomy as Effective as Standard RTѻý> Randomized trial a "game changer" for patients who have implant-based reconstruction, expert says Oct 04, 2023
<ѻý>In BRCA Breast Cancer, Prophylactic Salpingo-Oophorectomy Tied to Better Survivalѻý> PSO should be performed early, particularly for those with the BRCA1 variant, researchers say Oct 04, 2023
<ѻý>SBRT Noninferior to Conventional RT for Intermediate-Risk Prostate Cancerѻý> Treatment over 1 to 2 weeks achieves similar outcomes to therapy given for as long as 7.5 weeks Oct 03, 2023
<ѻý>FDA Advisors to Consider DFMO Maintenance for High-Risk Neuroblastoma in Kidsѻý> Lack of options for relapsed disease versus uncertainty about supporting data Oct 03, 2023
<ѻý>FDA Greenlights Test for Cancer-Predisposing Genetic Mutationsѻý> First-of-its-kind DNA test achieved 99% accuracy for variants in dozens of genes Oct 03, 2023
<ѻý>Sexual Activity Lowers Risk of Side Effects After Cervical Cancer Treatmentѻý> Intercourse and/or vaginal dilation reduces risk of vaginal stenosis Oct 03, 2023
<ѻý>Preoperative Algorithm Might Halve Unnecessary Oophorectomies in Childrenѻý> Researchers point to potential for reduction in lifelong consequences Oct 03, 2023
<ѻý>ABIM CEO Retirement Comes Amid Wave of Criticismѻý> Richard Baron, MD, plans to step down as pushback against MOC grows Oct 02, 2023
<ѻý>SABR Offers New Hope for Older Patients With Inoperable Kidney Cancerѻý> Phase II study shows 100% local control and cancer-specific survival after more than 3 years Oct 01, 2023
<ѻý>IV Immunoglobulin May Cut Infection Risk of Anti-BCMA Agents for Myelomaѻý> Small retrospective study finds fewer severe infections during periods of replacement therapy Sep 29, 2023
<ѻý>New Insight Into Hyperglycemia Risk With PI3K Inhibitor for Breast Cancerѻý> Significantly more common in community setting, predicted by high baseline HbA1c Sep 28, 2023
<ѻý>Anti-TIGIT Plus Immunotherapy 'Promising' in NSCLC, Esophageal Cancerѻý> Combination may "provide meaningful antitumor activity," researchers say Sep 28, 2023
<ѻý>Cancer Drug Shortages for Kids; Pharma Agrees to Price Talks; Catch-Up on Screeningѻý> News, features, and commentary about cancer-related issues Sep 28, 2023
<ѻý>Report: Persistence of Gender Inequalities in Cancer Care, and a Call to Actionѻý> Premature deaths, lack of access to services, leadership inequalities highlighted Sep 27, 2023
<ѻý>Cancer Risk in NAFLD Higher With Early Disease Onsetѻý> 52% greater risk of malignancy for patients diagnosed with fatty liver disease before age 45 Sep 27, 2023
<ѻý>SBRT Added to Standard Tx Boosts Outcomes in Oligometastatic Prostate Cancerѻý> Combination improved biochemical response and PFS compared with systemic treatment alone Sep 27, 2023
<ѻý>Study Confirms Better Survival for HPV-Positive Cervical Cancerѻý> Source, interpretation of negative tests remain open to speculation Sep 26, 2023
<ѻý>When Screening Guidelines Collide, Who Wins?ѻý> A closer look at conflicting colorectal cancer screening recommendations Sep 26, 2023
<ѻý>Frontline Combo Yields High Remission Rate in Hairy Cell Leukemiaѻý> And almost all complete responders in small trial achieved MRD negativity Sep 25, 2023
<ѻý>Reduced Mortality Seen in Cancer Survivors Who Meet Exercise Guidelinesѻý> Survivors classified as exercisers have 25% reduced risk of all-cause mortality, study shows Sep 23, 2023